Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R01 Clinical Trial Optional)

Organization National Institutes of HealthPosted 6 Nov 2024Deadline 7 May 2026 ⚠️
HHS-NIH1193.86693.242synopsis
Sign up free to applyFull description · apply link · all types
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Full Description

Opportunity Number: PAR-25-036 Document Type: synopsis CFDA Numbers: 93.866, 93.242

Read the full description

Sign up freeFree account · No credit card required